drugset / Trial / NCT00626028

Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing

NCT00626028

Phase 3 Completed 136 enrolled Mallinckrodt
RandomizedCrossoverOpen-labelDiagnostic

Summary

The primary purpose of this study is to compare the number of participants with reversible pulmonary hypertension (vasoreactivity) due to nitric oxide for inhalation and oxygen as compared to 100% oxygen.

Timeline

Start
2004-09
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitric Oxide Other / unclassified 80 ppm Inhaled
Subject Oxygen Other / unclassified 100 % Inhaled